Influence of the Calmodulin Antagonist EBB on Cyclin B1 and Cdc2-p34 in Human Drug-resistant Breast Cancer MCF-7/ADR Cells

• Published in: Clinical oncology and cancer research Vol. 5; no. 2; pp. 108 - 112
• Main Author: Xu Shi Yanhong Cheng Linglin Zou Dongsheng Xiong Yuan Zhou Ming Yang Dongmei Fan Xiaohua Dai Chunzheng Yang Huifang Zhu
• Format: Journal Article
• Language: English
• Published: 2008
• Subjects: 乳腺癌; 治疗方法; 细胞凋亡; 细胞周期蛋白
• ISSN: 1674-5361; 1868-324X

OBJECTIVE To investigate the influence of O-（4-ethoxyl-butyl）- berbamine （EBB） on the expression of cyclin B1 and cdc2-p34 in the human drug-resistant breast cancer MCF-7/ADR cell line. METHODS The MTT assay was used to assess the cytotoxicity of EBB. Different levels of EBB were added to different cell lines at series of time points solely or combined with doxorubicin （DOX） to detect the effect on the expression of cyclinB1 and cdc2-p34 by Western blots, cdc2-p34 tyrosine phosphorylation was detected by immunoprecipitation. In addition, apoptosis and cytoplastic Ca^2＋ concentrations were systematically examined by laser scanning confocal microscopy （LSCM）. RESULTS EBB showed little inhibitory activity on human umbilical vein endothelial cells （ECV304）, whereas EBB inhibited cell growth （IC50 range, 4.55-15.74 μmol/L） in a variety of sensitive and drug-resistance cell lines. EBB also down-regulated the expression of cyclin B1 and cdc2-p34 in a concentration and time dependent manner, which was an important reason for the G2/M phase arrest. EBB was shown to induce apoptosis of MCF-7/ADR cells while increasing the level of cytoplastic Ca^2＋. CONCLUSION The low cytotoxicity of EBB suggests it may be useful as a rational reversal agent. The effect of EBB on cell cycle arrest and related proteins, apoptosis, and cytoplastic Ca^2＋ concentration may be involved in reversing multidrug resistance.